These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23220039)

  • 1. [Advances in haploidentical transplantation in hematological malignancies].
    Castagna L; Blaise D
    Bull Cancer; 2012 Dec; 99(12):1141-51. PubMed ID: 23220039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children.
    Liu D; Huang X; Liu K; Xu L; Chen H; Han W; Chen Y; Zhang X; Jiang Q
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):469-77. PubMed ID: 18342790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.
    Chen X; Hale GA; Barfield R; Benaim E; Leung WH; Knowles J; Horwitz EM; Woodard P; Kasow K; Yusuf U; Behm FG; Hayden RT; Shurtleff SA; Turner V; Srivastava DK; Handgretinger R
    Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study.
    André-Schmutz I; Le Deist F; Hacein-Bey-Abina S; Vitetta E; Schindler J; Chedeville G; Vilmer E; Fischer A; Cavazzana-Calvo M
    Lancet; 2002 Jul; 360(9327):130-7. PubMed ID: 12126823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploidentical stem cell transplantation: the always present but overlooked donor.
    Spitzer TR
    Hematology Am Soc Hematol Educ Program; 2005; ():390-5. PubMed ID: 16304409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune reconstitution after haploidentical hematopoietic stem cell transplantation.
    Chang YJ; Zhao XY; Huang XJ
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):440-9. PubMed ID: 24315844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].
    Nguyen S; Chalandon Y; Lemarie C; Simon S; Masson D; Dhedin N; Suarez F; Renaud B; Charbonnier A; Yafour N; François S; Duléry R; Blaise D; Yakoub-Agha I; Rubio MT
    Bull Cancer; 2016 Nov; 103(11S):S229-S242. PubMed ID: 27842860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
    Huang X; Liu D
    Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
    Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
    Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic stem-cell transplantation from haploidentical donors using 'ex-vivo' T-cell depletion in pediatric patients with hematological malignancies: state of the art review.
    González-Vicent M; Díaz Perez MA
    Curr Opin Oncol; 2018 Nov; 30(6):396-401. PubMed ID: 30307414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-haploidentical hematopoietic SCT from collateral related donors without in vitro T-cell depletion for hematological malignancies.
    Zhang YY; Liu DH; Liu KY; Xu LP; Chen H; Han W; Wang Y; Huang XJ
    Bone Marrow Transplant; 2014 Apr; 49(4):496-501. PubMed ID: 24510070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation.
    Bashey A; Zhang X; Sizemore CA; Manion K; Brown S; Holland HK; Morris LE; Solomon SR
    J Clin Oncol; 2013 Apr; 31(10):1310-6. PubMed ID: 23423745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in haploidentical stem cell transplantation for hematologic malignancies.
    Montoro J; Sanz J; Sanz GF; Sanz MA
    Leuk Lymphoma; 2016 Aug; 57(8):1766-75. PubMed ID: 27424663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.
    Rizzieri DA; Koh LP; Long GD; Gasparetto C; Sullivan KM; Horwitz M; Chute J; Smith C; Gong JZ; Lagoo A; Niedzwiecki D; Dowell JM; Waters-Pick B; Liu C; Marshall D; Vredenburgh JJ; Gockerman J; Decastro C; Moore J; Chao NJ
    J Clin Oncol; 2007 Feb; 25(6):690-7. PubMed ID: 17228020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-derived natural killer cells infused after human leukocyte antigen-haploidentical hematopoietic cell transplantation: a dose-escalation study.
    Choi I; Yoon SR; Park SY; Kim H; Jung SJ; Jang YJ; Kang M; Yeom YI; Lee JL; Kim DY; Lee YS; Kang YA; Jeon M; Seol M; Lee JH; Lee JH; Kim HJ; Yun SC; Lee KH
    Biol Blood Marrow Transplant; 2014 May; 20(5):696-704. PubMed ID: 24525278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haploidentical bone marrow transplantation without T-cell depletion.
    Chang YJ; Huang XJ
    Semin Oncol; 2012 Dec; 39(6):653-63. PubMed ID: 23206842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Haploidentical 2- or 3-antigen-mismatched hematopoietic stem cell transplantation using in vivo Campath-1H].
    Kanda Y
    Rinsho Ketsueki; 2006 Jul; 47(7):607-17. PubMed ID: 16910570
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation in children with hematological malignancies across HLA barriers--reasonable alternative?
    Sedlácek P; Starý J; Vodváková S; Poloucková A; Gasová Z; Marinov I; Formánková R
    Neoplasma; 2001; 48(4):302-6. PubMed ID: 11712683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current role of T cell depletion in paediatric stem cell transplantation.
    Booth C; Lawson S; Veys P
    Br J Haematol; 2013 Jul; 162(2):177-90. PubMed ID: 23718232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.